Recurrence-free survival
|
---|
Variable
|
HR
|
95% CI
|
Pvalue
|
---|
Age at diagnosis
|
1.00
|
0.97-1.03
|
0.951
|
Nodal status
| | | |
Negative
|
1
| | |
Positive
|
3.08
|
1.66-5.73
|
<0.001
|
T stage
| | | |
T1
|
1
| | |
T2-4
|
1.31
|
0.66-2.58
|
0.439
|
p4E-BP1 S65
|
1.62
|
1.13-2.31
|
0.008
|
Overall survival
|
Variable
|
HR
|
95% CI
|
P
value
|
Age at diagnosis
|
1.04
|
1.01-1.07
|
0.003
|
Nodal status
| | | |
Negative
| | | |
Positive
|
1.29
|
0.75-2.23
|
0.355
|
T stage
| | | |
T1
| | | |
T2-4
|
1.02
|
0.58-1.81
|
0.945
|
pS6 S235/236
|
1.73
|
1.03-2.90
|
0.039
|
eEF2K
|
2.19
|
1.35-3.56
|
0.002
|
Pdcd4
|
0.42
|
0.25-0.70
|
0.001
|
- CI, confidence interval; HR, hazard ratio.